Skip to content

Comparison of Magnesium sulphate adjuvant Perineurally vs intravenously to levobupivacaine in usg guided supraclavicular block

Comparison of perineural and intravenous magnesium sulphate as an adjuvant to levobupivacaine in ultrasound â?? guided supraclavicular brachial plexus block: A prospective randomized trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048238
Enrollment
52
Registered
2022-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Perineural and intravenous magnesium sulphate: Group 1 perineural magnesium sulphate â?? patient will receive 0.5% levobupivacaine (24.5ml) with 250 mg of magnesium sulphate (0.5ml) tot

Sponsors

Chettinad Academy of Research and Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18 - 60 years 2.Both sexes 3. ASA Classes I,II and III patients 4. Patients posted for upper limb surgery below shoulder

Exclusion criteria

Exclusion criteria: 1.Patient refusal 2. Coagulopathy 3. History of allergy to local anesthetics 4. Infection at the site of block 5. Neurodeficit involving brachial plexus 6. Pregnant women 7. Patients with psychiatric behaviorn 8. ASA Class IV patients 9.Obese patients BMI >35kg/m2

Design outcomes

Primary

MeasureTime frame
To compare the duration of analgesia Timepoint: 2 years

Secondary

MeasureTime frame
â?¢ To compare the onset of sensory and motor block â?¢To compare the requirement of rescue analgesic in the postoperative period â?¢To compare the side effects (if any)Timepoint: 2 years

Countries

India

Contacts

Public ContactDr Koushallya Sri S

Chettinad Academy Of Research and Education

dranandmurugan@gmail.com9444486183

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026